IL-5 antagonists (Cengent)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIL-5 antagonists (Cengent)
Drug Alias NameIL-5 antagonists (SBI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-5 receptors inhibitors
TargetsInterleukin-5 receptors
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCengent Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCengent Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A